These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 16251538)

  • 1. The medical management of depression.
    Mann JJ
    N Engl J Med; 2005 Oct; 353(17):1819-34. PubMed ID: 16251538
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression.
    Zanardi R; Serretti A; Rossini D; Franchini L; Cusin C; Lattuada E; Dotoli D; Smeraldi E
    Biol Psychiatry; 2001 Sep; 50(5):323-30. PubMed ID: 11543734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine dysfunction and the pathophysiology and treatment of depression.
    Charney DS
    J Clin Psychiatry; 1998; 59 Suppl 14():11-4. PubMed ID: 9818625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
    Murphy GM; Hollander SB; Rodrigues HE; Kremer C; Schatzberg AF
    Arch Gen Psychiatry; 2004 Nov; 61(11):1163-9. PubMed ID: 15520364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.
    Morishita S; Arita S
    Eur Psychiatry; 2003 Dec; 18(8):418-20. PubMed ID: 14680720
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physical recovery is part of remission].
    Krankenpfl J; 2004; 42(3-4):110. PubMed ID: 15311907
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment.
    Putzhammer A; Schoeler A; Rohrmeier T; Sand P; Hajak G; Eichhammer P
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):303-8. PubMed ID: 15322730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversed diurnal variation in depression: associations with a differential antidepressant response, tryptophan: large neutral amino acid ratio and serotonin transporter polymorphisms.
    Joyce PR; Porter RJ; Mulder RT; Luty SE; McKenzie JM; Miller AL; Kennedy MA
    Psychol Med; 2005 Apr; 35(4):511-7. PubMed ID: 15856721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serotonin transporter and the activity regulated cytoskeleton-associated protein genes in antidepressant response and resistance: 5-HTTLPR and other variants.
    Calabrò M; Fabbri C; Crisafulli C; Albani D; Forloni G; Kasper S; Sidoti A; Velardi E; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
    Hum Psychopharmacol; 2018 Nov; 33(6):e2682. PubMed ID: 30426571
    [No Abstract]   [Full Text] [Related]  

  • 11. Digging for data on harms in duloxetine trials.
    Doshi P; Zito J; dosReis S
    BMJ; 2014 Jun; 348():g3578. PubMed ID: 24904123
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram.
    Arias B; Catalán R; Gastó C; Gutiérrez B; Fañanás L
    J Psychopharmacol; 2005 Mar; 19(2):166-72. PubMed ID: 15728438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of bipolar depression: an update.
    Thase ME
    Curr Psychiatry Rep; 2006 Dec; 8(6):478-88. PubMed ID: 17094928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
    Ishigooka J
    Nihon Rinsho; 2001 Aug; 59(8):1523-9. PubMed ID: 11519152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of selective serotonin reuptake inhibitor response: a 6-month follow-up.
    Serretti A; Zanardi R; Franchini L; Artioli P; Dotoli D; Pirovano A; Smeraldi E
    Pharmacogenetics; 2004 Sep; 14(9):607-13. PubMed ID: 15475734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder.
    Durham LK; Webb SM; Milos PM; Clary CM; Seymour AB
    Psychopharmacology (Berl); 2004 Aug; 174(4):525-9. PubMed ID: 12955294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.
    Kasper S; Tauscher J; Willeit M; Stamenkovic M; Neumeister A; Küfferle B; Barnas C; Stastny J; Praschak-Rieder N; Pezawas L; de Zwaan M; Quiner S; Pirker W; Asenbaum S; Podreka I; Brücke T
    World J Biol Psychiatry; 2002 Jul; 3(3):133-46. PubMed ID: 12478878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nowhere patients.
    Tomba E
    Psychother Psychosom; 2012; 81(2):69-72. PubMed ID: 22261819
    [No Abstract]   [Full Text] [Related]  

  • 19. Sequence analysis of the serotonin transporter and associations with antidepressant response.
    Kraft JB; Slager SL; McGrath PJ; Hamilton SP
    Biol Psychiatry; 2005 Sep; 58(5):374-81. PubMed ID: 15993855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Resumption-inhibition in presynaptic action: the medicinal].
    Schubert-Zsilavecz M; Stark H
    Pharm Unserer Zeit; 2004; 33(4):282-7. PubMed ID: 15287688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.